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Abstract
Introduction: The pathogenesis of osteoarthritis (OA) is characterized by the production of high amounts of nitric
oxide (NO), as a consequence of up-regulation of chondrocyte-inducible nitric oxide synthase (iNOS) induced by
inflammatory cytokines. NO donors represent a powerful tool for studying the role of NO in the cartilage in vitro.
There is no consensus about NO effects on articular cartilage in part because the differences between the NO
donors available. The aim of this work is to compare the metabolic profile of traditional and new generation NO
donors to see which one points out the osteoarthritic process in the best way.
Methods: Human healthy and OA chondrocytes were isolated from patients undergoing joint replacement surgery, and
primary cultured. Cells were stimulated with NO donors (NOC-12 or SNP). NO production was evaluated by the Griess
method, and apoptosis was quantified by flow cytometry. Mitochondrial function was evaluated by analysing respiratory
chain enzyme complexes, citrate synthase (CS) activities by enzymatic assay, mitochondrial membrane potential (Δψm)
by JC-1 using flow cytometry, and ATP levels were measured by luminescence assays. Glucose transport was measured
as the uptake of 2-deoxy-[3H]glucose (2-[3H]DG). Statistical analysis was performed using the Mann-Whitney U test.
Results: NOC-12 liberates approximately ten times more NO2
- than SNP, but the level of cell death induced was
not as profound as that produced by SNP. Normal articular chondrocytes stimulated with NOC-12 had reduced
activity from complexes I, III y IV, and the mitochondrial mass was increased in these cells. Deleterious effects on
ΔΨm and ATP levels were more profound with SNP, and this NO donor was able to reduce 2-[3H]DG levels. Both
NO donors had opposite effects on lactate release, SNP diminished the levels and NOC-12 lead to lactate
accumulation. OA chondrocytes incorporate significantly more 2-[3H]DG than healthy cells.
Conclusions: These findings suggest that the new generation donors, specifically NOC-12, mimic the OA
metabolic process much better than SNP. Previous results using SNP have to be considered prudently since most
of the effects observed can be induced by the interactions of secondary products of NO.
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Introduction
Articular cartilage is an avascular, non-insulin-sensitive
tissue that utilizes glucose as the main energy source and
as a precursor for glycosaminoglycan synthesis and a regu-
lator of gene expression. Degradation of articular cartilage
is a hallmark of osteoarthritis (OA) [1] and is associated
with aberrant glucose metabolism [2,3]. On the other
hand, the pathogenesis of OA is characterized by the pro-
duction of high amounts of nitric oxide (NO), conse-
quence of up-regulation of chondrocyte-inducible nitric
oxide synthase (iNOS) induced by inflammatory cytokines,
such as IL-1b and TNFa, and other factors [4-7].
Although it has been reported that NO causes chon-
drocyte apoptosis [8-10], production of high levels of
endogenous NO by over-expression of the iNOS gene in
transfected chondrocytes has not been found to cause
cell death [11]. Other reports have proposed NO to be a
physiologic regulator of mitochondrial respiration in
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chondrocytes [10,12,13]. A variety of NO donors have
been demonstrated to suppress energy production by
mitochondrial respiration in different cell types [14,15],
an effect enhanced at low oxygen tensions [16], and
firstly reported in chondrocytes by Johnston and colla-
borators [12].
Chondrocytes are highly glycolytic resident cells of
articular cartilage that metabolize glucose as a primary
substrate for ATP production [17]. However, oxygen
does diffuse into articular cartilage and articular chon-
drocytes possess mitochondria and respire in vivo [18].
The superficial and middle zones of articular cartilage
are not anoxic [19], and in this context, mitochondrial
oxidative phosphorylation (OXPHOS) is 18 times as effi-
cient in ATP generation as is glycolysis [14,20]. Further-
more, OXPHOS may account for up to one fourth of
total steady-state ATP production within articular carti-
lage, and possibly more under conditions of increased
energy demands associated with cartilage stress [21].
Besides this, mitochondria are important in regulating
both caspase-dependent and caspase-independent apop-
totic pathways [22-26].
It is generally accepted that the quantities of available
oxygen and glucose can fluctuate considerably in con-
nective tissues such as articular cartilage, growth plates
and the intervertebral disc [27-29]. Articular chondro-
cytes consume less oxygen in comparison with most
other cell types [30]. Consequently, anaerobic glycolysis
forms the principal source of cellular ATP in cartilage.
The direct investigation of the function of exogenous
NO production on articular chondrocytes has been ham-
pered by the lack of uniformity between the different types
of NO donor compounds [31]. Since the past decade, the
diazeniumdiolates began to replace traditional donors,
such as SIN-1 (3-morpholinosydnonimine), SNP (sodium
nitroprusside), SNAP (S-nitroso-N-acetylpenicillamine)
and S-nitrosogluthathione, as sources of exogenous NO
production [32], because have been shown to be reliable
sources of NO under a variety of culture conditions
[33,34]. The main advantages of these compounds are:
known rates of NO generation, NO generation rates cov-
ering a wide range, spontaneity of NO generation and ten-
able generation of NO redox forms [34].
For all these reasons, besides the classical donor SNP, we
used a diazeniumdiolate, NOC-12 (N-ethyl-2(1-ethyl-2
hydroxy-2-nitrosohydrazine), with a half-life of 327 minutes
(determined at 22°C, pH 7.4) [33], for exogenous NO pro-
duction, to further investigate the conditions in which NO
is cytotoxic to chondrocytes, and compare the different
effects induced by the two different types of NO donors.
We wished to determine whether NO modulates the
pathogenesis of OA, inducing apoptosis by means of the
inhibition of mitochondrial function
Materials and methods
Cartilage acquisition and cell isolation
Normal human cartilage from femoral heads (joint
replacement surgery) and knees (joint replacement
surgery and autopsies) was obtained from 11 adult
donors without history of joint disease and who had
macroscopically normal cartilage (mean age ± SD
46.5 ± 10.5 years); human OA cartilage was obtained
from the femoral heads of 12 patients (age 70 ± 12.6
years). All patients and healthy donors have signed the
informed consent and the project was approved by the
Regional Ethical Committee from Galicia (Spain).
Small cartilage fragments were digested as previously
described [35].
Primary culture of chondrocytes
Chondrocytes were recovered and plated at high density
(4 × 106 per 162 cm2 flask; Costar, Cambridge, MA,
USA) in DMEM (Life Technologies, Paisley, UK) supple-
mented with 100 units/ml penicillin, 100 μg/ml strepto-
mycin, 1% glutamine, and 10% FCS (Life Technologies).
Chondrocytes were incubated at 37°C in a humidified
gas mixture containing 5% CO2 balanced with air.
Chondrocytes were used at weeks 2 to 3 at confluence
in primary culture. Cell viability was assessed by trypan
blue dye exclusion, and stained cells were discarded to
carry out experiments.
General procedure and NO donor compounds employed
NO donor compounds were added from 60 mM stock
solution dissolved in 0.1 M NaOH (NOC-12) and
10 mM stock solution dissolved in medium (SNP). This
NO donor compound was freshly prepared before each
experiment but NOC-12 was stored as 60 mM stock
solutions in 0.1 mM NaOH at -20°C. Chondrocytes
were first seeded in DMEM with 5% FCS inactivated for
24 hours, and then the NO donor compound was added
directly to the culture medium and allowed to incubate
for an additional 5-, 12-, 24- and 48-hour period,
depending on each experiment. Experiments without
glucose were carried out in DMEM glucose-free med-
ium (Life Technologies) supplemented in the same way
as the standard.
Quantification of nitrites
The NO production of chondrocyte cells was measured
by estimating nitrite accumulation using the Griess
reagent (1% sulphanilamide and 0.1% N-(1-naphthyl)-
ethylenediamine dihydrochloride in 5% H3PO4) (Sigma,
St Louis, MO) as previously described [36]. Chondro-
cytes were cultured in 96-well plates (5 × 104) and sti-
mulated with different NO donors for 5, 24 and
48 hours.
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DNA labelling technique with propidium iodide for flow
cytometry analysis
Chondrocytes (500,000 cells/well in a 6-well plate) were
incubated with different NO donors (0.5, 1.0 and
2.0 mM SNP and NOC-12) for 12, 24 and 48 hours.
Then cells were fixed in 70% ethanol at 4°C for 60 min-
utes, washed and incubated with RNAse (50 μg/ml) and
propidium iodide (PI, 100 μg/ml) for 15 minutes at
room temperature in the dark and kept at 4°C. PI fluor-
escence of nuclei was measured by flow cytometry on a
FACScan (Becton and Dickinson, Mountain View, CA,
USA) using a 560-nm dichromatic mirror and a 600-nm
band pass filter. Data are expressed as percent apoptotic
(hypodiploid) nuclei.
Morphological evidence of apoptosis
For morphological studies, chondrocytes were cultured in
8-well slides (Costar) and treated with 1 mM of different
NO donors for 24 hours. The cells were then washed
with cold PBS, fixed in acetone/ethanol 70% (1:1)
for 10 minutes at 4°C, stained with 49,6-dianidino-2-
phenylindole dihydrochloride (DAPI, 2 mg/ml) (Sigma)
for 10 minutes in the dark, mounted in glycergel (DAKO,
Hamburg, Germany), and observed by fluorescence
microscopy (Olympus, BX-UCB, Center Valley, PA).
Measurement of the MRC complex activities in digitonin-
permeabilized chondrocytes
Untreated, SNP-treated (5 hours) and NOC-12-treated
(24 hours) chondrocytes (at least 10 × 106) were collected
by trypsinization, washed with PBS, and sedimented at
150 g for 5 minutes at 4°C. Digitonin-permeabilized
chondrocyte homogenates (10 to 50 μl per ml of test
volume) were used to measure the activities of the
respiratory chain enzymes and citrate synthase (CS) in a
DU-650 spectrophotometer (Beckman Instruments, Palo
Alto, CA, USA) as previously described [35].
Determination of mitochondrial membrane potential
(ΔΨm)
To measure the ΔΨm of chondrocytes, the fluorescent
probe JC-1 (5,5’,6,6’- tetrachloro-1,1’,3,3’-tetraethylbenzi-
midazole carbocyanide iodide) (Molecular Probes, Inc.,
Eugene, OR, USA) was used. JC-1 exists as a monomer
at low values of ΔΨm (green fluorescence), whereas it
forms aggregates at high ΔΨm (red fluorescence).
Briefly, chondrocytes were cultured in 6-well plates (5 ×
105) and stimulated with different NO donors for 5, 12
and 24 hours; after that they were prepared as pre-
viously described [35].
Assay of intracellular ATP
To assay intracellular ATP, we used a commercial biolu-
miscence kit (ATPLite, PerkinElmer Inc., Boston, MA,
USA). Chondrocytes were cultured in 96-well plates (5 ×
104) and stimulated with different NO donors for 24
hours (100 μl); after this, 50 μl of lysis solution were added
and mixed for 5 minutes; subsequently the enzymatic sub-
strate (luciferase/luciferine) was added. The kit supplies a
standard that gives reference values. Readers were carried
out in a microbeta counter (PerkinElmer Inc.).
2-Deoxy-[3H] glucose uptake
To determinate the glucose uptake levels, normal chon-
drocytes were cultured in 24- well plates (Visiplate,
PerkinElmer Inc.) at 2 × 105 cells per well in DMEM with-
out glucose and 5% inactivated calf serum for 24 h at 37°C.
Later, cells were stimulated with 10 μM of different donors
for 24 hours at 37°C in DMEM without glucose and subse-
quently 10 μCi 2-deoxy-(3H)glucose (2-(3H)DG) was added
to cells in DMEM without glucose for 0 minutes, 15 min-
utes and 1 hour at 37°C. Cells were washed with cold PBS
pH 7.4; later, 50 μl of solvable (PerkinElmer Inc.) was
added to lysate cells and mixed vigorously for 5 minutes.
Lastly, 500 μl of scintillation liquid was added (Ultima
Gold, PerkinElmer, Inc.) and mixed for 2 minutes; glucose
uptake was estimated by means of a microbeta counter
(MicroBeta TriLux (PerkinElmer, Inc.)).
Quantification of lactic acid
Enzymatic determination of lactic acid in chondrocyte cul-
ture supernatants was performed using Lactate Reagent
(Spinreact, Girona, Spain). Chondrocytes were cultured in
96-well plates (5 × 104) and stimulated with different NO
donors for 24 hours; 10 μl of supernatant were mixed with
10 μl of lactate reagent and incubated for 5 minutes at
room temperature. The absorption was estimated by an
automated plate reader (Ultrospec 1000, Amersham Phar-
macia Biotech, Uppsala, Sweden) at 505 nm; this method
is linear towards lactate values of 150 mg/dl.
Data analysis
Data analysis was performed with SPSS software, version
12.05 (SPSS, Chicago, IL, USA). Results are expressed as
the mean ± SD. Individual donors were studied in dupli-
cate; cells from different donors were not pooled in any
experiment. Comparisons between groups were carried
out using the Mann-Whitney two-tailed U-test. P-values
≤ 0.05 were considered significant.
Results
NO release by different NO donors
We observed that kinetic liberation of NO changes
between different NO donors. The diazeniumdiolate
NOC-12 liberated approximately ten times more NO2
-
than SNP. NO2
- accumulation in supernatants of normal
chondrocytes treated with different NO donors depend-
ing on time and concentration (Figure 1).
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Effect of NO on cell death of normal human articular
chondrocytes
NO donors damage the nuclear DNA of human articular
chondrocytes in very different ways. By means of flow cyto-
metry with PI, we could observe that the percentage of
death cells (expressed as hypodiplod DNA percentage) was
much higher with SNP than NOC-12 (Additional file 1);
with 1 mM SNP at 24 hours: 25.9 ± 23.3 versus 0.8 ± 0.5
(P ≤ 0.05) compared with 1 mM NOC-12 at 24 hours:
4.3 ± 1.9 versus 0.8 ± 0.5 (P ≤ 0.05) (Figure 2A). However,
with higher concentrations of NOC-12 (2 mM at
48 hours), the percentage of apoptosis reached 21.6 ± 8.5%
(Additional file 1). Besides this, when the cells were stained
with DAPI we could see that the only NO donor able to
induce the fragmentation of the nucleus and the formation
of apoptotic bodies was SNP (Figure 2B). The only effect of
NOC-12 on the nucleus of chondrocytes was the acquisi-
tion of a globule-like aspect (Figure 2B).
NOC-12 alters the activity of the complexes of the
mitochondrial respiratory chain (MRC) in articular
chondrocytes
Previous results obtained in our laboratory showed that
the activity of the complex IV is significantly lower in
normal chondrocytes stimulated with 1 mM SNP at
5 hours than in control cells [10] (Table 1). In relation
with the enzymatic activity of the MRC of normal chon-
drocytes treated with the diazeniumdiolate compound
NOC-12, the activities of all complexes were signifi-
cantly lower than in control cells, except complex II
(Table 1). Enzyme activities were referred to the specific
activity of CS to correct for mitochondrial volume.
NO causes depolarization of the mitochondria in normal
chondrocytes
The relative ratio of red/green fluorescence (ratio of
normal mitochondrial polarization to mitochondrial
depolarization) intensity values showed that in normal
human chondrocyte cultures 1 mM SNP at 24 hours
decreased the ratio of red/green fluorescence in compar-
ison with untreated cells (1.91 ± 1.9 versus 3.5 ± 2.9;
P ≤ 0.01) (Figure 3B). In addition, 1 mM SNP caused an
increase in the cell population with mitochondrial depo-
larization (12.2 ± 6.6 versus 33.6 ± 13.1%; P ≤ 0.05)
(Figure 3A). On the other hand, NOC-12 induced mito-
chondrial depolarization, as the percentage of cells with
normal polarization diminished, with 1 mM NOC-12 at 24
hours: 27.7 ± 17.9 versus 14.1 ± 3.6; P ≤ 0.05; (Figure 3A),
and the percentage of cells with depolarization increased:
12.2 ± 6.6 versus 18.8 ± 11.3; P ≤ 0.05 (Figure 3A). This
Figure 1 Nitric oxide (NO) donors differ from the amount of NO2
- released. NO2
- accumulation in supernatants of normal chondrocytes
treated with different NO donors for 24 hours in standard culture conditions. The lines show the dose-dependent increase of NO accumulation
in all cases. Values are the mean ± SD; n = 5. SNP, sodium nitroprusside; NOC-12, N-ethyl-2(1-ethyl-2 hydroxy-2-nitrosohydrazine.
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finding also can be observed with decreasing ratio of red/
green fluorescence in comparison with untreated cells
(2.2 ± 1.5 versus 3.5 ± 2.9; P ≤ 0.05) (Figure 3B). However,
the NO donor that induced the strongest changes in the
mitochondrial membrane potential was SNP.
NO abolishes ATP generation by chondrocytes in culture
NO has a detrimental effect on the generation of ATP
by normal chondrocytes (Additional file 2). With NOC-
12, the intracellular ATP levels were significantly lower
than in control cells, with 1mM NOC-12 at 24 hours:
0.40 ± 0.16 versus 0.57 ± 0.19 (P ≤ 0.05). Again, the NO
donor that induced the most dramatic changes was
SNP, as it reduced the intracellular ATP levels practi-
cally to zero (Figure 4).
Chondrocytic lactate production is strongly influenced by
NO donor type
NO donors have very different effects on lactate release
by normal articular chondrocytes. The only donor that
Figure 2 Nitric oxide (NO) effect on chondrocyte apoptosis. (A) Cell death levels in chondrocytes treated with different NO donors was determined
by the iodide propidium (PI) method. Control chondrocytes were treated with 1 mM sodium nitroprusside (SNP) and 1 mM N-ethyl-2(1-ethyl-2
hydroxy-2-nitrosohydrazine (NOC-12) for 24 hours. Data are expressed as a percentage of apoptotic (hypodiploid) nuclei. Values are the mean ± SD; n =
5. *P ≤ 0.05 versus untreated chondrocytes (control). (B) Cellular changes induced by NO on normal human chondrocytes were analysed by 49,6-
diamino-2-phenylindole dihydrochloride (DAPI staining) and fluorescence microscopy. Shown is a representative example of five experiments.








Age, years 49.8 ± 21.2 (14) 44.2 ± 19.4 (5) 59.7 ± 18.9 (11)
Proteins, mg/ml 3.1 ± 0.9 (14) 2.8 ± 1.4 (5) 4.2 ± 1.4 (11)
CS enzymatic activity (nmol/min/mg protein) 108.9 ± 38.5 (14) 146.9 ± 54.7 (5) 106.6 ± 26.2 (11)
Mitochondrial complex activitya
Complex I 30.1 ± 13.4 (14) 6.8 ± 2.3 (5)* 22.8 ± 19.1 (11)
Complex II 7.4 ± 2.3 (14) 6.8 ± 1.6 (5) 10.2 ± 1.81 (11)
Complex III 53.5 ± 18.4 (14) 35.2 ± 9.3 (5)* 46.3 ± 9.7 (11)
Complex IV 61.2 ± 8.3 (14) 15.7 ± 3.1 (5)* 40.2 ± 11.3 (11)*
Values are the mean ± SD (number). *P ≤ 0.05 versus untreated chondrocytes. aCS-corrected complex activity is expressed as (nmol/minute/mg protein)/(CS-
specific activity) × 100. NO, nitric oxide; NOC-12, N-ethyl-2(1-ethyl-2 hydroxy-2-nitrosohydrazine; CS, citrate synthase; Complex I, rotenone-sensitive NADH-
coenzime Q1 reductase; complex II, succinate dehydrogenase; complex III, antimycin-sensitive ubiquinol cytochrome c reductase; complex IV, cytochrome c
oxidase. Chondrocytes were treated with NOC-12 for 24 hours and SNP for 5 hours.
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Figure 3 Effect of nitric oxide (NO) donors on mitochondrial membrane potential. (A) Fluorescence-activated cell sorter analysis of
mitochondrial membrane potential in human chondrocytes. Untreated and treated normal chondrocytes with NO donors were stained with
5,5’,6,6’- tetrachloro-1,1’,3,3’-tetraethylbenzimidazole carbocyanide iodide (JC-1) and analysed by flow cytometry. Photomultiplier settings were
adjusted to detect JC-1 monomer fluorescence signals on the filter 1 (FL1) detector (green fluorescence) and JC-1 aggregate fluorescence signals
on the FL2 detector (red fluorescence). Shown is an example of chondrocytes treated with 1 mM SNP and 2 mM N-ethyl-2(1-ethyl-2 hydroxy-2-
nitrosohydrazine (NOC-12) for 24 hours. (B) Quantification of red and green fluorescence. Histograms represent the JC-1 fluorescence of normal
cells and those treated with NO donors. Green fluorescence (open graph) increases, whereas red fluorescence (solid graph) decreases in the
NOC-12 and sodium nitroprusside (SNP)-treated chondrocytes, suggesting a reduction of the mitochondrial membrane potential, and therefore,
a decrease in the red/green ratio. Shown is an example at 24 hours. Results are the mean ± SD; n = 5. *P ≤ 0.05 versus untreated chondrocytes
(control).
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induced a significant fall in these values was SNP, with 2
mM SNP at 24 hours: 1.01 ± 0.3 versus 2.30 ± 0.58 (P ≤
0.05) (Table 2). The new generation donor NOC-12
induced a substantial increase in lactate production,
with 0.5 mM NOC-12 at 24 hours: 2.91 ± 0.58 versus
2.30 ± 0.58, although this increase was not statistically
significant (Table 2).
SNP reduces glucose uptake by normal articular
chondrocytes
Uptake of 2-(3H)DG by normal chondrocytes cultured
under μM SNP concentrations (10 μM) for either
15 minutes or 1 hour was approximately 20% lower
than that found in their respective controls (Figure 5).
On the contrary, 2-(3H)DG uptake in normal chondro-
cytes stimulated with NOC-12 did not change relative
to the control. In this set of experiments, μM NO
donors concentrations were employed; the reason is
because in most of these cases, when mM concentra-
tions were used, this caused the cells to rise (above all,
SNP) and the quantifications showed false positives.
Detrimental effect of NO on chondrocyte viability
depends on glucose levels
To assess the impact of glucose levels on cell viability
after NO treatment, we carried out experiments with
both NO donors (SNP and NOC-12) using only one
constant concentration (1 mM) and increasing glucose
concentrations (from 0.75 to 5 mM). The percentage of
death cells decreased as glucose concentration increased,
only when SNP was employed as NO donor (Figure 6).
No significant results were found in this issue when
NOC-12 was used.
Glucose uptake by OA chondrocytes in basal conditions is
more efficient than by normal chondrocytes
Chondrocytes were maintained for 15 minutes or 1 hour
in culture media without glucose and a non-metaboliz-
able analogue of glucose: 2-(3H)DG. Basal 2-(3H)DG
uptake was identical in normal and OA chondrocytes
incubated for 15 minutes; however, the basal 2-(3H)DG
uptake in OA chondrocytes was significantly higher
than in normal chondrocytes (23889.9 ± 9941.6 versus
14669.5 ± 2776.1; P ≤ 0.05) (Figure 7), when cells were
maintained for 1 hour in culture.
Discussion
Traditionally, the increase of endogenous NO produc-
tion by human articular cartilage has been associated
with joint degeneration. NO donors have been used so
far to mimic the OA process in vitro, and they represent
a powerful tool of study. However, in vitro models with
different NO donors have not resolved what the role of
NO is in cartilage degradation due to the lack of unifor-
mity that exists between the different types of NO com-
pounds [31]. The differential effects of NO are partly
due to the type of NO donors and cell used [37]. The
Figure 4 ATP generation by normal chondrocytes treated with
different nitric oxide (NO) donors. Articular chondrocytes were
treated with 1 mM sodium nitroprusside (SNP) and 2 mM N-ethyl-2
(1-ethyl-2 hydroxy-2-nitrosohydrazine (NOC-12) for 24 hours. Then
the ATP assay was performed as described in Materials and
methods. Values are the mean ± SD; n = 7. *P ≤ 0.05 versus
untreated chondrocytes (control).
Table 2 Values of lactate release in cultures of normal
chondrocytes treated with different NO donors
compounds for 24 hours
Lactate
(μM/5 × 104 cells)
Control normal chondrocytes 2.30 ± 0.58 (7)
0.5 mM SNP 1.83 ± 0.65 (7)
1 mM SNP 1.33 ± 0.38 (7) †
2 mM SNP 1.01 ± 0.30 (7) †
0.5 mM NOC-12 2.91 ± 0.58 (7)
1 mM NOC-12 2.90 ± 0.66 (7)
2 mM NOC-12 2.86 ± 0.77 (7)
Values are the mean ± SD (number). NO, nitric oxide; SNP, sodium
nitroprusside; NOC-12, N-ethyl-2(1-ethyl-2 hydroxy-2-nitrosohydrazine.
Figure 5 Nitric oxide (NO) influence on 2-deoxy-(3H) glucose
uptake by normal chondrocytes. Effect of the NO donors sodium
nitroprusside (SNP) and N-ethyl-2(1-ethyl-2 hydroxy-2-
nitrosohydrazine (NOC-12) on the uptake of 2-deoxy-(3H) glucose by
normal chondrocytes for 15 minutes. The detailed procedure is
described in Materials and methods. Values are the mean ± SD; n =
7. *P ≤ 0.05 versus untreated chondrocytes (control).
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biochemistry of NO is complex because of the reactions
of NO itself, the interactions of secondary products of
NO and the overall chemical environment under which
NO is produced [38].
In our study, we employed two NO donor types: the
traditional compound SNP, that is used in the majority
of studies, and one diazeniumdiolate: NOC-12. It has
been reported that the traditional donor SNP does not
spontaneously release NO in the absence of redox acti-
vation [34]. Diazeniumdiolates, also denominated as
NONOate, or NOC, have begun to replace traditional
donors as sources of exogenous NO production [32]
and have been shown to be reliable sources of NO
under a variety of culture conditions [33,34]. For these
reasons, the diazeniumdiolate compound NOC-12, with
a half-life of 327 minutes (determined at 22°C, pH 7.4)
[33] was used for exogenous NO production to further
investigate the conditions in which NO is cytotoxic to
chondrocytes. A primary basis for the use of diazenium-
diolates is that many of them decompose spontaneously
in aqueous media to release the critical bioregulatory
species [34]. The main advantages of these compounds
are known rates of NO generation, NO generation rates
covering a wide range, spontaneity of NO generation
and tenable generation of NO redox forms.
The precise role of NO in the induction of chondrocyte
death is repeatedly debated. Treatment with classical NO
donors consistently induces apoptosis in cultured chon-
drocytes [6,8,10,39], whereas the production of high
levels of endogenous NO by the over-expression of the
iNOS gene in transfected chondrocytes has not been
found to cause cell death [11]. This discrepancy might be
the result of using chemical NO donors, which not only
generate reactive nitrogen species but also produce var-
ious secondary reactions depending on the cellular milieu
with in vitro experiments [40]. Also, an anti-apoptotic
role has been addressed in several review articles [41-45].
Specifically, del Carlo and collaborators showed that
compounds that only release NO, such as the diazenium-
diolates NOC-5 and NOC-12, do not cause chondrocyte
cell death and can even be protective under certain con-
ditions of oxidative stress [39]. It is likely that persistent
spontaneous release of NO is necessary for the protective
effect and that peroxynitrite and cyanide contribute to
the cytotoxic effect of NO donors [37]. Chondrocyte cell
death from NO occurs under conditions where other
reactive oxygen species (ROS) are also generated [39].
Figure 6 The effect of nitric oxide (NO) on chondrocyte viability depends on glucose levels. Articular chondrocytes were cultured in
medium with crescent glucose concentrations and treated with 1 mM sodium nitroprusside (SNP) and 1 mM N-ethyl-2(1-ethyl-2 hydroxy-2-
nitrosohydrazine (NOC-12) for 24 hours. Data are expressed as a percentage of apoptotic (hypodiploid) nuclei. Values are the mean ± SD; n = 3.
Figure 7 Osteoarthritis (OA) chondrocytes are efficient cells in
the uptake of glucose. Differences between human articular normal
and OA chondrocytes in the uptake of 2-deoxy-(3H)glucose for 1 hour.
The detailed procedure is described in Materials and methods. Values
are the mean ± SD; n = 12. *P ≤ 0.05 versus normal chondrocytes.
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Chondrocyte death does not correlate with the amount
of NO released by NO donors. Similar to other authors
[46], our results showed that SNP is the least potent in
terms of producing exogenous NO in chondrocyte cul-
ture, although it is the most potent inducer of chondro-
cyte death. The amount of NO produced by NOC-12 was
10-fold higher than the NO produced by SNP, but the
level of cell death induced was not as profound as that
produced by SNP. As previously shown in our laboratory
[10], SNP was able to induce formation of apoptotic
bodies, which are produced from cells undergoing cell
death by apoptosis. However, we observed that NOC-12
increased the hypodiploid nuclei number without forma-
tion of apoptotic bodies, which is probably related to
another type of programmed cell death. Recently it has
been proposed that autophagy is another type of pro-
grammed cell death than happens in the human articular
cartilage as well [47]. The increase in the number of
hypopliod nuclei and the observation of some morpholo-
gic changes as vacuole formation seems to relate NOC-
12 with autophagy (personal data).
It is believed unlikely that NO is the sole mediator of
SNP-induced chondrocyte death and peroxynitrite, a
reaction product of NO and superoxide anions, or the
primary by-products of the decomposition of SNP, such
as the cyanide aninon or pentacy-anoferrate complex,
might contribute to its cytotoxicity [34,48]. It is unclear
whether chondrocyte apoptosis is the major mechanism
of cartilage degradation or merely a by-product of tissue
degeneration [46].
Mitochondria comprise a target of NO and there is
accumulating evidence that inhibition of respiration may
contribute to the pro-apoptotic effect of NO by ΔΨm
alteration, transition-pore opening and release of cyto-
chrome c [45,49]. There is increasing evidence about
the importance of mitochondria in OA pathology. Pre-
viously, we showed that the activity of the mitochondrial
complexes II and III is lower in OA than in normal
human chondrocytes; this produces a decrease in ATP
levels as well as a higher ROS generation [12,35]. The
relevance of the MRC inhibition in human chondrocytes
is already known, the inhibition of complexes III and V
of the MRC induces an inflammatory response, which
could be especially relevant in relation to prostaglandin
E2 (PGE2) production via mitochondrial Ca
2+ exchange,
ROS production, and nuclear factor (NF)-B activation
[50]. More recently, Rego and collaborators have found
that the predisposition to the development of OA is
related to some haplogroups of mitochondrial respira-
tory genes of chondrocytes [51]. Also, chondrocytes are
not the only joint cells affected in OA pathology and, a
recent study has shown that SNP reduces the survival of
OA synoviocytes by regulating mitochondrial functional-
ity, as well as the proteins controlling the cell cycle [52].
Analysis of the MRC showed that at 5 hours, SNP
reduced the activity of complex IV by 30%; furthermore,
SNP induced depolarisation of the mitochondrial mem-
brane [10]. In this study we show that NOC-12 induces
depolarisation of the mitochondrial membrane as well as
SNP, but to a lesser extent (10%); however, it had a more
radical effect on MRC activity than SNP, this donor reduces
the activities of all the complexes except complex II
(complex I by 80%, complex III by 33% and complex IV
by 75%). These results show that the inhibition of the MRC
complexes is not the main cause of cell death induction in
chondrocytes by NO. On the other hand, CS activity was
increased about 40% in NOC-12-treated chondrocytes, and
this fact has been correlated with an increment of the mito-
chondrial mass [30]; Nisoli and collaborators also suggested
that NO is implicated in the regulation of energy metabo-
lism, possibly through the enhancement of mitochondria
formation [53]. Similar findings were previously found in
OA chondrocytes [35] but not in SNP-treated ones [10].
Therefore, an increase in mitochondrial mass could be a
mechanism by which OA chondrocytes as well as NOC-
12-treated cells, compensate for the electron transfer
deficiency resulting from dysfunction in several com-
plexes and the consequent low production of ATP per
mitochondrion, as has already been reported by Maneiro
and collaborators [35].
In relation to ATP synthesis both donors had a detri-
mental effect on it, but once more SNP was the com-
pound with the most important deleterious effect. With
respect to lactate production, SNP reduced the levels in a
significant way compared to the control cells; on the con-
trary, NOC-12 increased lactate production by chondro-
cytes although this increment was not statistical
significant. A dysfunction in complexes I, III and IV com-
promises the electron transfer pathway; this defect could
be solved increasing the anaerobic metabolism to avoid
excess production of ROS, and these findings are in
agreement with the increase of lactate levels after incuba-
tion with NOC-12. These results are consistent with the
findings reported by Tomita and collaborators on NOC-
18-treated chondrocytes, another member of the diaze-
niumdiolate family [13]. Because NO inhibited the
respiration of mitochondria, cellular glycolysis was
enhanced significantly, the effect on cellular ATP levels
was rather mild, despite the inhibition of mitochondrial
respiration by NO. Thus, the enhanced glycolysis in
NOC-18-treated chondrocytes could theoretically com-
pensate for the inhibition of mitochondrial synthesis by
approximately 46% [13]. On the other hand, the build-up
of lactic acid will have detrimental effects on the extracel-
lular matrix and may contribute to the pathogenesis and
progression of OA [54].
Chondrocytes are highly glycolytic resident cells of
articular cartilage that metabolize glucose as a primary
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substrate for ATP production [17]. The Pasteur effect
arises in articular cartilage; in this way anaerobic glyco-
lysis and lactate production are involved in respiratory
metabolism of articular cartilage even under aerobic
conditions [21,55,56]. An anaerobic metabolism could be
beneficial for OA, since the products of glucose degrada-
tion (lactate and pyruvate) would act as ROS scavengers
[57,58], and would assure ATP production even under
conditions of mitochondrial dysfunction (defects in CRM
complexes and high NO production) [35].
Only the traditional donor SNP was able to reduce
glucose uptake by normal chondrocytes. Previously, we
showed that the inhibition of complex IV with sodium
azide modified the survival of the chondrocytes, but its
effect was greater when glucose was absent. A possible
explanation is that the inhibition of complex IV exclu-
sively is not enough to induce apoptosis and other cellu-
lar events; such a reduction in the intake of glucose
needs to be present to induce it [10]. The glucose
dependency of chondrocytes arises with the fact that the
effect of SNP on chondrocyte apoptosis correlates with
glucose levels; the lower the glucose levels in the media,
the highest the apoptotic levels induced.
Finally, OA chondrocytes incorporated more glucose
than healthy chondrocytes under the standard experi-
mental conditions used in this study. These findings are
in consonance with a higher lactate production by OA
chondrocytes than control chondrocytes (personal data).
Furthermore, this up-regulation can be considered a
protective mechanism that maximizes the cell’s ability to
capture glucose and thus to overcome stressful condi-
tions, such as glucose scarcity or even deprivation
[59,60], or just to compensate CRM defects. On the
other hand, these findings can somehow explain the
ROS contribution to the pathogenesis of OA [61,62]; no
changes in glucose incorporation by normal chondro-
cytes can suggest a protective mechanism against the
deleterious effects of excessive intracellular glucose, as
seen in other cells [63], and the incapacity of OA chon-
drocytes to regulate this can trigger ROS accumulation
in OA cartilage. Others authors have reported that basal
glucose uptake is identical in normal and OA chondro-
cytes [63]; the reasons for these discrepancies are
unclear but the observed differences may be related to
the culture conditions used in these studies.
Conclusions
The new generation donor NOC-12 mimics the meta-
bolic OA situation much better than the classical NO
donor SNP. Taking account of all the results obtained
in this study, previous findings using SNP have to be
considered very cautiously, and most of the effects
observed in human chondrocytes probably cannot be
attributed exclusively to NO.
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